Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

PR Newswire

NEW YORK, Sept. 22, 2026

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardelyx, Inc. (NASDAQ: ARDX) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardelyx securities between January 13, 2025 and August 6, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/ardelyx-inc-ardx-class_action_lawsuit.

Ardelyx Case Details

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:

1. Ardelyx was experiencing increasing payer-related access and reimbursement barriers affecting patient access to XPHOZAH and IBSRELA;
2. more stringent prior authorization and step-edit requirements were slowing new-patient starts and delaying prescription fulfillment;
3. these payer utilization-management processes were negatively impacting Ardelyx's commercial performance and growth prospects for XPHOZAH and IBSRELA;
4. as a result, Defendants overstated Ardelyx's commercial performance and growth prospects for XPHOZAH and IBSRELA; and
5. as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

What's Next for Ardelyx Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/ardelyx-inc-ardx-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Ardelyx you have until November 16, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Ardelyx Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Ardelyx Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | info@bgandg.com

Attorney advertising.

Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bronstein-gewirtz--grossman-llc-urges-ardelyx-inc-investors-to-act-class-action-filed-alleging-investor-harm-302884294.html

SOURCE Bronstein, Gewirtz & Grossman, LLC